ADVERTISEMENT
COVID-19, SARS-CoV-2, coronavirus, pandemic, vaccine, vaccine trials, combination, mix and match, immunity, antibodies, T cells, Pfizer, Moderna, AstraZeneca, clinical trials
COVID-19 Vaccine Combos Aim to Boost Immunity
Mix-and-match shots could simplify vaccine rollout and stimulate more-robust immune responses. Ongoing clinical trials will soon give answers.
COVID-19 Vaccine Combos Aim to Boost Immunity
COVID-19 Vaccine Combos Aim to Boost Immunity

Mix-and-match shots could simplify vaccine rollout and stimulate more-robust immune responses. Ongoing clinical trials will soon give answers.

Mix-and-match shots could simplify vaccine rollout and stimulate more-robust immune responses. Ongoing clinical trials will soon give answers.

vaccine design, disease & medicine

COVID-19, SARS-CoV-2, coronavirus, pandemic, pseudovirus, chimeric virus, disease & medicine, techniques, HIV, VSV, vaccine, variants, mutations
What Pseudoviruses Bring to the Study of SARS-CoV-2
Amanda Heidt | Feb 16, 2021 | 7 min read
Engineered viruses that don’t replicate provide a tractable model for scientists to safely study SARS-CoV-2, including research into vaccine efficacy and emerging variants.
SARS-CoV-2, COVID-19, coronavirus, pandemic, virus, vaccine, vaccination, outbreak, infectious disease, Johnson & Johnson, Moderna, Pfizer, drug development
One-Shot COVID-19 Vaccine Prevents Severe Disease
Asher Jones | Jan 29, 2021 | 2 min read
Johnson & Johnson’s vaccine is less effective at preventing COVID-19 than other approved vaccines are, but experts say it could still be an important tool in curbing the pandemic.
Infographic: How Vaccines Train Innate Immunity
Shawna Williams | Nov 1, 2020 | 1 min read
A recent study elucidates some of the changes that occur in the body after inoculation with a tuberculosis vaccine.
COVID-19, SARS-CoV-2, pandemic, coronavirus, clinical trials, safety, vaccine, Johnson & Johnson, Janssen
Johnson & Johnson Pauses COVID-19 Vaccine Trials
Amanda Heidt | Oct 13, 2020 | 3 min read
The company voluntarily paused its studies, including one in Phase 3, after an unexplained illness in a patient.
Infographic: Mix and Match
Ruth Williams | Jul 13, 2020 | 1 min read
How llamas and superglue might lead to antiviral therapies
Jean Macnamara’s Multiple Causes, 1931
Catherine Offord | Jul 13, 2020 | 3 min read
The medical scientist made important contributions to polio treatment and Australian environmental policy—despite substantial resistance.
covid-19, pandemic, SARS-CoV-2, coronavirus, vaccine, fauci, FDA, medicine, vaccine development
FDA to Require 50 Percent Efficacy for COVID-19 Vaccines
Amanda Heidt | Jul 1, 2020 | 2 min read
Vaccine experts divided on whether that level of protection is too low or too demanding.
Infographic: Vaccines on Film
Ruth Williams | Jun 1, 2020 | 1 min read
How an experimental preparation technique could make vaccines easier to transport, store, and administer
Vaccines Without Vials, Fridges, or Needles
Ruth Williams | Jun 1, 2020 | 3 min read
A novel preparation technique could facilitate vaccine preservation, transportation, and administration.
an image of a molecule with three intertwined components
SARS-CoV-2–Fighting T Cells Found in Recovered Patients
Shawna Williams | May 15, 2020 | 2 min read
While the finding doesn’t prove people become immune to the virus after infection, it is good news for vaccine development.
Updated July 9
Track COVID-19 Vaccines Advancing Through Clinical Trials
The Scientist | Apr 7, 2020 | 10+ min read
Find the latest updates in this one-stop resource, including efficacy data and side effects of approved shots, as well as progress on new candidates entering human studies.
COVID-19 Vaccine Developers Gain Enhanced Access to Supercomputers
Lisa Winter | Mar 27, 2020 | 2 min read
Federal agencies, academic institutions, and industrial partners are joining forces to combat COVID-19 using artificial intelligence.
US Primate Centers Work to Protect Animals from COVID-19
Ashley Yeager | Mar 19, 2020 | 4 min read
Rhesus macaques can be infected with SARS-CoV-2, leading primate center scientists to try to prevent outbreaks in their colonies, especially as experiments on coronavirus start.
Infographic: Preventing a Swine Pandemic
Katarina Zimmer | Jan 13, 2020 | 2 min read
With millions of pigs killed due to a major outbreak of African swine fever virus in Asia, researchers have intensified efforts to find a vaccine quickly.
Mardis on the Future of Clinical Genomics
The Scientist | Jul 15, 2019 | 1 min read
Meet researcher Elaine Mardis of the Institute for Genomic Medicine at Nationwide Children’s Hospital in Ohio and coauthor of a feature article on cancer vaccines.
ADVERTISEMENT